Figure 3.
Figure 3. Specific peptide inhibition of HIV-1 Env-mediated fusion with primary target cell types. Designated primary target cells infected with vCB-21R-LacZ were preincubated with peptides at the indicated concentrations for 1 hour at 37°C. Target cells were then mixed with HeLa effector cells coinfected with vTF7-3 and vCB43 (Ba-L) or vCB-41 (LAV). Effector 89.6 Env-expressing HeLa cells were prepared by transfection of pSC59/89.6 and infection with vTF7-3. Fusion assay was performed as described in “Materials and methods.” (A) PBMC targets. (B) Primary macrophage targets. Error bars indicate SD of mean values obtained from duplicate fusion assays.

Specific peptide inhibition of HIV-1 Env-mediated fusion with primary target cell types. Designated primary target cells infected with vCB-21R-LacZ were preincubated with peptides at the indicated concentrations for 1 hour at 37°C. Target cells were then mixed with HeLa effector cells coinfected with vTF7-3 and vCB43 (Ba-L) or vCB-41 (LAV). Effector 89.6 Env-expressing HeLa cells were prepared by transfection of pSC59/89.6 and infection with vTF7-3. Fusion assay was performed as described in “Materials and methods.” (A) PBMC targets. (B) Primary macrophage targets. Error bars indicate SD of mean values obtained from duplicate fusion assays.

Close Modal

or Create an Account

Close Modal
Close Modal